| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 11,082.0 | 11,477.0 |
| Profit before tax | 53.0 | 88.0 |
| Net income | 38.0 | 79.0 |
| EPS (diluted, $ a share) | $0.73 | $1.51 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | -51.9% |
|---|---|
| Revenue, year on year | -3.4% |
| Operating margin | 1.0% |
10-Q filed with the SEC, NYSE: MOH. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Molina Healthcare, Inc.: key numbers
- Share price
- $221.21Close, Nov 17
- Market cap
- $11.5B
- Shares outstanding
- 52.2MLatest SEC cover page
- Sector
- Finance
- Industry
- Hospital & Medical Service PlansSIC 6324
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Molina Healthcare, Inc.
All →Molina Healthcare Insider Dale B. Wolf Sells $330K of Stock
Dale B. Wolf sold 1,600 shares of Molina Healthcare, Inc. at $206.12 a share, worth $330K in total on Nov 13, 2026. Shares held after the trade: 14,337 (-10.0%).
- Value
- $330K
- Shares
- 1,600
- Price
- $206.12
- Holding change
- -10.0%
- Trade date
- Nov 13, 2026
Molina Healthcare Insider Richard M. Schapiro Sells $159K of Stock
Richard M. Schapiro sold 782 shares of Molina Healthcare, Inc. at $203.94 a share, worth $159K in total on Nov 10, 2026. Shares held after the trade: 11,833 (-6.2%).
- Value
- $159K
- Shares
- 782
- Price
- $203.94
- Holding change
- -6.2%
- Trade date
- Nov 10, 2026
Molina Healthcare CLO Jeff D. Barlow Sells $1.62M of Stock
Jeff D. Barlow, CLO, sold 8,000 shares of Molina Healthcare, Inc. at $203.07 a share, worth $1.62M in total on Nov 10, 2026. Shares held after the trade: 59,313 (-11.9%).
- Value
- $1.62M
- Shares
- 8,000
- Price
- $203.07
- Role
- CLO
- Holding change
- -11.9%
- Trade date
- Nov 10, 2026
Molina Healthcare Investor Presentation
Molina Healthcare senior management will participate in the UBS Global Healthcare Conference on November 9, 2026. During the event, the company intends to reaffirm its full-year 2026 guidance, including GAAP diluted EPS of at least $2.38 and adjusted diluted EPS of at least $5.25.
- Counterparty
- UBS
Molina Healthcare Financial Results
Molina Healthcare reported third quarter 2026 financial results, including total revenue of $11.08 billion and GAAP diluted EPS of $0.73. The company reaffirmed its full-year 2026 guidance, expecting premium revenue of approximately $42 billion and adjusted earnings of at least $5.25 per diluted share.
- Term
- Q3 2026
“We are pleased with our third quarter results in this challenging environment and reaffirm our full year guidance. With the apparent plateauing of medical cost trend, which remains at elevated levels, and the strength of recent rate updates for 2027, we believe we are likely observing the beginning of the turn in Medicaid margins.”
Joseph Zubretsky, President and Chief Executive Officer